Achillion Pharmaceuticals (ACHN) Posts Wider-Than-Expected Q3 Loss
Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) reported a wider-than-expected loss in the third quarter due to costs incurred from clinical testing of its hepatitis C virus protease inhibitors. [More...]
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here